Swedish Orphan International Overview

  • Founded
  • 1988
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 51
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Swedish Orphan International General Information

Description

Provider of human leukocyte derived interferon and related drugs. The company specializes in the development, marketing and distribution of pharmaceutical products, focusing on orphan drugs (niche products) with unmet medical needs that can be used in the treatment of rare disorders and life-threatening diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Distributors (Healthcare)
Pharmaceuticals
Primary Office
  • 112 76 Stockholm
  • Sweden
+46 08-697 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Swedish Orphan International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Swedish Orphan International‘s full profile, request access.

Request a free trial

Swedish Orphan International Patents

Swedish Orphan International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5391713-A Immuno-affinity chromatography of solution, elution, precipitation with thiocyanate solution, then ion exchanging Expired - Lifetime 20-Jun-1989 000000000 0
EP-0478659-B1 Interferon purification process Expired - Lifetime 20-Jun-1989 000000000
EP-0478659-A1 Interferon purification process. Granted 20-Jun-1989 C07K14/56

Swedish Orphan International Executive Team (1)

Name Title Board Seat Contact Info
Bo Jesper Hansen Ph.D Chief Executive Officer
To view Swedish Orphan International’s complete executive team members history, request access »

Swedish Orphan International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Swedish Orphan International Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Swedish Orphan International‘s full profile, request access.

Request a free trial